Literature DB >> 21327743

Bone health issues in sarcoidosis.

Nadera J Sweiss1, Elyse E Lower, Peter Korsten, Timothy B Niewold, Murray J Favus, Robert P Baughman.   

Abstract

Sarcoidosis affects the bone directly in only a minority of patients. Nonetheless, bone health should be considered in the management of all patients with sarcoidosis. Deficiency in vitamin D, an important contributor to bone health, has been linked to autoimmune disease incidence. Studies have shown that patients with sarcoidosis frequently have low levels of vitamin D-25 but may have normal or increased levels of vitamin D-1,25. In addition, granuloma formation has been linked to a failure of the innate immune system, which could be related to a deficiency in vitamin D, although this relationship has not been fully characterized. Furthermore, many patients with sarcoidosis are treated with corticosteroids, which are known to induce osteoporosis. Therefore, bone health may be impacted in several ways in sarcoidosis--by direct involvement with granulomas, vitamin D deficiency, or corticosteroid therapy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21327743      PMCID: PMC3311464          DOI: 10.1007/s11926-011-0170-1

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  57 in total

1.  Vitamin D and sarcoidosis.

Authors:  Om P Sharma
Journal:  Curr Opin Pulm Med       Date:  2010-09       Impact factor: 3.155

2.  Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response.

Authors:  Philip T Liu; Steffen Stenger; Huiying Li; Linda Wenzel; Belinda H Tan; Stephan R Krutzik; Maria Teresa Ochoa; Jürgen Schauber; Kent Wu; Christoph Meinken; Diane L Kamen; Manfred Wagner; Robert Bals; Andreas Steinmeyer; Ulrich Zügel; Richard L Gallo; David Eisenberg; Martin Hewison; Bruce W Hollis; John S Adams; Barry R Bloom; Robert L Modlin
Journal:  Science       Date:  2006-02-23       Impact factor: 47.728

Review 3.  Vitamin D deficiency.

Authors:  Michael F Holick
Journal:  N Engl J Med       Date:  2007-07-19       Impact factor: 91.245

4.  Bisphosphonate-induced bronchoconstriction in aspirin-sensitive asthma.

Authors:  G Rolla; C Bucca; L Brussino
Journal:  Lancet       Date:  1994-02-12       Impact factor: 79.321

5.  Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement.

Authors:  Robert P Baughman; Marjolein Drent; Mani Kavuru; Marc A Judson; Ulrich Costabel; Roland du Bois; Carlo Albera; Martin Brutsche; Gerald Davis; James F Donohue; Joachim Müller-Quernheim; Rozsa Schlenker-Herceg; Susan Flavin; Kim Hung Lo; Barry Oemar; Elliot S Barnathan
Journal:  Am J Respir Crit Care Med       Date:  2006-07-13       Impact factor: 21.405

Review 6.  Calcium and vitamin D in sarcoidosis: how to assess and manage.

Authors:  Robert R Burke; Benjamin A Rybicki; D Sudhaker Rao
Journal:  Semin Respir Crit Care Med       Date:  2010-07-27       Impact factor: 3.119

7.  Successful tumor necrosis factor alpha blockade treatment in therapy-resistant sarcoidosis.

Authors:  Kai U Ulbricht; Matthias Stoll; Janine Bierwirth; Torsten Witte; Reinhold E Schmidt
Journal:  Arthritis Rheum       Date:  2003-12

8.  A double-blinded, randomized, placebo-controlled trial of infliximab in subjects with active pulmonary sarcoidosis.

Authors:  Milton D Rossman; Lee S Newman; Robert P Baughman; Alvin Teirstein; Steven E Weinberger; Wallace Miller; Bruce E Sands
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2006-10       Impact factor: 0.670

9.  Elevated 1, 25-dihydroxyvitamin D levels are associated with protracted treatment in sarcoidosis.

Authors:  Dashant Kavathia; John D Buckley; Dhanwada Rao; Benjamin Rybicki; Robert Burke
Journal:  Respir Med       Date:  2010-01-13       Impact factor: 3.415

10.  High serum IFN-alpha activity is a heritable risk factor for systemic lupus erythematosus.

Authors:  T B Niewold; J Hua; T J A Lehman; J B Harley; M K Crow
Journal:  Genes Immun       Date:  2007-06-21       Impact factor: 2.676

View more
  15 in total

1.  Vitamin D status in sarcoidosis: a cross-sectional study.

Authors:  Ilias C Papanikolaou; Brian Tabila; Kristina Tabila; Zea Borok; Om Sharma; Michael K Gould
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2018-04-28       Impact factor: 0.670

2.  Intrascrotal and osseous sarcoidosis mimicking intrascrotal organ cancer and bony metastasis.

Authors:  Shin-Ichi Nureki; Eishi Miyazaki; Mari Yamasue; Ryuichi Takenaka; Masaru Ando; Jun-Ichi Kadota
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2017-04-28       Impact factor: 0.670

Review 3.  [Musculoskeletal manifestations of sarcoidosis].

Authors:  P Korsten; G Chehab
Journal:  Z Rheumatol       Date:  2017-06       Impact factor: 1.372

4.  The Burden of Comorbidity and Complexity in Sarcoidosis: Impact of Associated Chronic Diseases.

Authors:  Pilar Brito-Zerón; Nihan Acar-Denizli; Antoni Sisó-Almirall; Xavier Bosch; Fernanda Hernández; Sergi Vilanova; Mireia Villalta; Belchin Kostov; Marina Paradela; Marcelo Sanchez; José Ramírez; Africa Muxí; Antonio Berruezo; Celeste Galceran-Chaves; Antoni Xaubet; Carles Agustí; Jacobo Sellarés; Manuel Ramos-Casals
Journal:  Lung       Date:  2017-12-11       Impact factor: 2.584

5.  Bone density is normal and does not change over 2 years in sarcoidosis.

Authors:  M J Bolland; M L Wilsher; A Grey; A M Horne; S Fenwick; G D Gamble; I R Reid
Journal:  Osteoporos Int       Date:  2014-08-30       Impact factor: 4.507

6.  TREM-2 Receptor Expression Increases with 25(OH)D Vitamin Serum Levels in Patients with Pulmonary Sarcoidosis.

Authors:  Maria Bucova; Magda Suchankova; Elena Tibenska; Eva Tedlova; Juraj Demian; Ivan Majer; Helena Novosadova; Miroslav Tedla
Journal:  Mediators Inflamm       Date:  2015-06-16       Impact factor: 4.711

7.  Randomised controlled trial of vitamin D supplementation in sarcoidosis.

Authors:  Mark J Bolland; Margaret L Wilsher; Andrew Grey; Anne M Horne; Sheryl Fenwick; Greg D Gamble; Ian R Reid
Journal:  BMJ Open       Date:  2013-10-23       Impact factor: 2.692

8.  Bone Mineral Loss and Fracture in Sarcoidosis: A Systematic Review and Meta-Analysis.

Authors:  Wai Chung Yong; Sikarin Upala; Anawin Sanguankeo
Journal:  Arch Rheumatol       Date:  2018-09-05       Impact factor: 1.472

9.  Goldilocks, vitamin D and sarcoidosis.

Authors:  Robert P Baughman; Elyse E Lower
Journal:  Arthritis Res Ther       Date:  2014       Impact factor: 5.156

Review 10.  Musculoskeletal involvement in sarcoidosis.

Authors:  Akasbi Nessrine; Abourazzak Fatima Zahra; Harzy Taoufik
Journal:  J Bras Pneumol       Date:  2014 Mar-Apr       Impact factor: 2.624

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.